Registro:

Referencias:

• Liberman, A.C., Druker, J., Perone, M.J., Arzt, E., Glucocorticoids in the regulation of transcription factors that control cytokine synthesis (2007) Cytokine Growth Factor Rev, 18, pp. 45-56
• Petta, I., Dejager, L., Ballegeer, M., Lievens, S., Tavernier, J., De Bosscher, K., The interactome of the glucocorticoid receptor and its influence on the actions of glucocorticoids in combatting inflammatory and infectious diseases (2016) Microbiol Mol Biol Rev, 80, pp. 495-522
• Ratman, D., Vanden Berghe, W., Dejager, L., Libert, C., Tavernier, J., Beck, I.M., How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering (2013) Mol Cell Endocrinol, 380, pp. 41-54
• Refojo, D., Liberman, A.C., Holsboer, F., Arzt, E., Transcription factor-mediated molecular mechanisms involved in the functional cross-talk between cytokines and glucocorticoids (2001) Immunol Cell Biol, 79, pp. 385-394
• Stahn, C., Buttgereit, F., Genomic and nongenomic effects of glucocorticoids (2008) Nat Clin Pract Rheumatol, 4, pp. 525-533
• Busillo, J.M., Cidlowski, J.A., The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore (2013) Trends Endocrinol Metab, 24, pp. 109-119
• D'Mello, C., Le, T., Swain, M.G., Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation (2009) J Neurosci, 29, pp. 2089-2102
• Konsman, J.P., Parnet, P., Dantzer, R., Cytokine-induced sickness behaviour: mechanisms and implications (2002) Trends Neurosci, 25, pp. 154-159
• Plotkin, S.R., Banks, W.A., Kastin, A.J., Comparison of saturable transport and extracellular pathways in the passage of interleukin-1 alpha across the blood-brain barrier (1996) J Neuroimmunol, 67, pp. 41-47
• Rivest, S., Lacroix, S., Vallières, L., Nadeau, S., Zhang, J., Laflamme, N., How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli (2000) Proc Soc Exp Biol Med, 223, pp. 22-38
• Watkins, L.R., Goehler, L.E., Relton, J.K., Tartaglia, N., Silbert, L., Martin, D., Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication (1995) Neurosci Lett, 183, pp. 27-31
• Capuron, L., Miller, A.H., Immune system to brain signaling: neuropsychopharmacological implications (2011) Pharmacol Ther, 130, pp. 226-238
• Pereda, M.P., Lohrer, P., Kovalovsky, D., Perez Castro, C., Goldberg, V., Losa, M., Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas (2000) Exp Clin Endocrinol Diabetes, 108, pp. 202-207
• Turrin, N.P., Rivest, S., Unraveling the molecular details involved in the intimate link between the immune and neuroendocrine systems (2004) Exp Biol Med (Maywood), 229, pp. 996-1006
• Cruz-Topete, D., Cidlowski, J.A., One hormone, two actions: anti-and pro-inflammatory effects of glucocorticoids (2015) Neuroimmunomodulation, 22, pp. 20-32
• Howell, M.P., Muglia, L.J., Effects of genetically altered brain glucocorticoid receptor action on behavior and adrenal axis regulation in mice (2006) Front Neuroendocrinol, 27, pp. 275-284
• Kleiman, A., Tuckermann, J.P., Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice (2007) Mol Cell Endocrinol, 275, pp. 98-108
• Barnes, P.J., Adcock, I.M., Glucocorticoid resistance in inflammatory diseases (2009) Lancet, 373, pp. 1905-1917
• Bertini, R., Bianchi, M., Ghezzi, P., Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor (1988) J Exp Med, 167, pp. 1708-1712
• Edwards, C.K., III, Yunger, L.M., Lorence, R.M., Dantzer, R., Kelley, K.W., The pituitary gland is required for protection against lethal effects of Salmonella typhimurium (1991) Proc Natl Acad Sci U S A, 88, pp. 2274-2277
• MacPhee, I.A., Antoni, F.A., Mason, D.W., Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids (1989) J Exp Med, 169, pp. 431-445
• Ramachandra, R.N., Sehon, A.H., Berczi, I., Neuro-hormonal host defence in endotoxin shock (1992) Brain Behav Immun, 6, pp. 157-169
• Refojo, D., Liberman, A.C., Giacomini, D., Carbia Nagashima, A., Graciarena, M., Echenique, C., Integrating systemic information at the molecular level: cross-talk between steroid receptors and cytokine signaling on different target cells (2003) Ann N Y Acad Sci, 992, pp. 196-204
• Ruzek, M.C., Pearce, B.D., Miller, A.H., Biron, C.A., Endogenous glucocorticoids protect against cytokine-mediated lethality during viral infection (1999) J Immunol, 162, pp. 3527-3533
• Evans, R.M., The steroid and thyroid hormone receptor superfamily (1988) Science, 240, pp. 889-895
• Kumar, R., Thompson, E.B., Gene regulation by the glucocorticoid receptor: structure: function relationship (2005) J Steroid Biochem Mol Biol, 94, pp. 383-394
• Beck, I.M., Vanden Berghe, W., Vermeulen, L., Yamamoto, K.R., Haegeman, G., De Bosscher, K., Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases (2009) Endocr Rev, 30, pp. 830-882
• Glass, C.K., Rose, D.W., Rosenfeld, M.G., Nuclear receptor coactivators (1997) Curr Opin Cell Biol, 9, pp. 222-232
• Bledsoe, R.K., Montana, V.G., Stanley, T.B., Delves, C.J., Apolito, C.J., McKee, D.D., Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition (2002) Cell, 110, pp. 93-105
• Cain, D.W., Cidlowski, J.A., Specificity and sensitivity of glucocorticoid signaling in health and disease (2015) Best Pract Res Clin Endocrinol Metab, 29, pp. 545-556
• Oakley, R.H., Cidlowski, J.A., Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids (2011) J Biol Chem, 286, pp. 3177-3184
• Busillo, J.M., Azzam, K.M., Cidlowski, J.A., Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome (2011) J Biol Chem, 286, pp. 38703-38713
• Ligr, M., Li, Y., Logan, S.K., Taneja, S., Melamed, J., Lepor, H., Mifepristone inhibits GRbeta coupled prostate cancer cell proliferation (2012) J Urol, 188, pp. 981-988
• Lewis-Tuffin, L.J., Jewell, C.M., Bienstock, R.J., Collins, J.B., Cidlowski, J.A., Human glucocorticoid receptor beta binds RU-486 and is transcriptionally active (2007) Mol Cell Biol, 27, pp. 2266-2282
• Charmandari, E., Chrousos, G.P., Ichijo, T., Bhattacharyya, N., Vottero, A., Souvatzoglou, E., The human glucocorticoid receptor (hGR) beta isoform suppresses the transcriptional activity of hGRalpha by interfering with formation of active coactivator complexes (2005) Mol Endocrinol, 19, pp. 52-64
• Oakley, R.H., Jewell, C.M., Yudt, M.R., Bofetiado, D.M., Cidlowski, J.A., The dominant negative activity of the human glucocorticoid receptor beta isoform Specificity and mechanisms of action (1999) J Biol Chem, 274, pp. 27857-27866
• Sousa, A.R., Lane, S.J., Cidlowski, J.A., Staynov, D.Z., Lee, T.H., Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform (2000) J Allergy Clin Immunol, 105, pp. 943-950
• Chikanza, I.C., Mechanisms of corticosteroid resistance in rheumatoid arthritis: a putative role for the corticosteroid receptor beta isoform (2002) Ann N Y Acad Sci, 966, pp. 39-48
• Honda, M., Orii, F., Ayabe, T., Imai, S., Ashida, T., Obara, T., Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis (2000) Gastroenterology, 118, pp. 859-866
• Piotrowski, P., Burzynski, M., Lianeri, M., Mostowska, M., Wudarski, M., Chwalinska-Sadowska, H., Glucocorticoid receptor beta splice variant expression in patients with high and low activity of systemic lupus erythematosus (2007) Folia Histochem Cytobiol, 45, pp. 339-342
• Koga, Y., Matsuzaki, A., Suminoe, A., Hattori, H., Kanemitsu, S., Hara, T., Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children (2005) Pediatr Blood Cancer, 45, pp. 121-127
• Shahidi, H., Vottero, A., Stratakis, C.A., Taymans, S.E., Karl, M., Longui, C.A., Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia (1999) Biochem Biophys Res Commun, 254, pp. 559-565
• Lu, N.Z., Collins, J.B., Grissom, S.F., Cidlowski, J.A., Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor (2007) Mol Cell Biol, 27, pp. 7143-7160
• Cain, D.W., Cidlowski, J.A., Immune regulation by glucocorticoids (2017) Nat Rev Immunol, 17, pp. 233-247
• Cooper, M.S., Stewart, P.M., 11Beta-hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation (2009) J Clin Endocrinol Metab, 94, pp. 4645-4654
• Stegk, J.P., Ebert, B., Martin, H.J., Maser, E., Expression profiles of human 11beta-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases (2009) Mol Cell Endocrinol, 301, pp. 104-108
• Zbánková, S., Bryndová, J., Leden, P., Kment, M., Svec, A., Pácha, J., 11Beta-hydroxysteroid dehydrogenase 1 and 2 expression in colon from patients with ulcerative colitis (2007) J Gastroenterol Hepatol, 22, pp. 1019-1023
• Liberman, A.C., Antunica-Noguerol, M., Arzt, E., Modulation of the glucocorticoid receptor activity by post-translational modifications (2014) Nucl Recept Res, 1, pp. 1-15
• Golebiowski, F., Matic, I., Tatham, M.H., Cole, C., Yin, Y., Nakamura, A., System-wide changes to SUMO modifications in response to heat shock (2009) Sci Signal, 2
• Holmstrom, S., Van Antwerp, M.E., Iñiguez-Lluhi, J.A., Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy (2003) Proc Natl Acad Sci U S A, 100, pp. 15758-15763
• Le Drean, Y., Mincheneau, N., Le Goff, P., Michel, D., Potentiation of glucocorticoid receptor transcriptional activity by sumoylation (2002) Endocrinology, 143, pp. 3482-3489
• Tian, S., Poukka, H., Palvimo, J.J., Jänne, O.A., Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor (2002) Biochem J, 367, pp. 907-911
• Iñiguez-Lluhí, J.A., Pearce, D., A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy (2000) Mol Cell Biol, 20, pp. 6040-6050
• Carbia-Nagashima, A., Gerez, J., Perez-Castro, C., Paez-Pereda, M., Silberstein, S., Stalla, G.K., RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia (2007) Cell, 131, pp. 309-323
• Druker, J., Liberman, A.C., Antunica-Noguerol, M., Gerez, J., Paez-Pereda, M., Rein, T., RSUME enhances glucocorticoid receptor SUMOylation and transcriptional activity (2013) Mol Cell Biol, 33, pp. 2116-2127
• Paakinaho, V., Kaikkonen, S., Makkonen, H., Benes, V., Palvimo, J.J., SUMOylation regulates the chromatin occupancy and anti-proliferative gene programs of glucocorticoid receptor (2014) Nucleic Acids Res, 42, pp. 1575-1592
• Davies, L., Karthikeyan, N., Lynch, J.T., Sial, E.A., Gkourtsa, A., Demonacos, C., Cross talk of signaling pathways in the regulation of the glucocorticoid receptor function (2008) Mol Endocrinol, 22, pp. 1331-1344
• Antunica-Noguerol, M., Budziñski, M.L., Druker, J., Gassen, N.C., Sokn, M.C., Senin, S., The activity of the glucocorticoid receptor is regulated by SUMO conjugation to FKBP51 (2016) Cell Death Differ, 23, pp. 1579-1591
• Kotaja, N., Karvonen, U., Jänne, O.A., Palvimo, J.J., The nuclear receptor interaction domain of GRIP1 is modulated by covalent attachment of SUMO-1 (2002) J Biol Chem, 277, pp. 30283-30288
• Panse, V.G., Hardeland, U., Werner, T., Kuster, B., Hurt, E., A proteome-wide approach identifies sumoylated substrate proteins in yeast (2004) J Biol Chem, 279, pp. 41346-41351
• Pountney, D.L., Raftery, M.J., Chegini, F., Blumbergs, P.C., Gai, W.P., NSF, Unc-18-1, dynamin-1 and HSP90 are inclusion body components in neuronal intranuclear inclusion disease identified by anti-SUMO-1-immunocapture (2008) Acta Neuropathol, 116, pp. 603-614
• Zhou, W., Ryan, J.J., Zhou, H., Global analyses of sumoylated proteins in Saccharomyces cerevisiae Induction of protein sumoylation by cellular stresses (2004) J Biol Chem, 279, pp. 32262-32268
• Pratt, W.B., Toft, D.O., Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery (2003) Exp Biol Med (Maywood), 228, pp. 111-133
• Schülke, J.P., Wochnik, G.M., Lang-Rollin, I., Gassen, N.C., Knapp, R.T., Berning, B., Differential impact of tetratricopeptide repeat proteins on the steroid hormone receptors (2010) PLoS One, 5
• Holownia, A., Mroz, R.M., Kolodziejczyk, A., Chyczewska, E., Braszko, J.J., Increased FKBP51 in induced sputum cells of chronic obstructive pulmonary disease patients after therapy (2009) Eur J Med Res, 14, pp. 108-111
• Storer, C.L., Dickey, C.A., Galigniana, M.D., Rein, T., Cox, M.B., FKBP51 and FKBP52 in signaling and disease (2011) Trends Endocrinol Metab, 22, pp. 481-490
• Woodruff, P.G., Boushey, H.A., Dolganov, G.M., Barker, C.S., Yang, Y.H., Donnelly, S., Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids (2007) Proc Natl Acad Sci U S A, 104, pp. 15858-15863
• Matsushita, R., Hashimoto, A., Tomita, T., Yoshitawa, H., Tanaka, S., Endo, H., Enhanced expression of mRNA for FK506-binding protein 5 in bone marrow CD34 positive cells in patients with rheumatoid arthritis (2010) Clin Exp Rheumatol, 28, pp. 87-90
• Baker, R.G., Hayden, M.S., Ghosh, S., NF-kappaB, inflammation, and metabolic disease (2011) Cell Metab, 13, pp. 11-22
• Erlejman, A.G., De Leo, S.A., Mazaira, G.I., Molinari, A.M., Camisay, M.F., Fontana, V., NF-kappaB transcriptional activity is modulated by FK506-binding proteins FKBP51 and FKBP52: a role for peptidyl-prolyl isomerase activity (2014) J Biol Chem, 289, pp. 26263-26276
• Hayden, M.S., Ghosh, S., NF-kappaB in immunobiology (2011) Cell Res, 21, pp. 223-244
• Nakamura, N., Shimaoka, Y., Tougan, T., Onda, H., Okuzaki, D., Zhao, H., Isolation and expression profiling of genes upregulated in bone marrow-derived mononuclear cells of rheumatoid arthritis patients (2006) DNA Res, 13, pp. 169-183
• Park, J., Kim, M., Na, G., Jeon, I., Kwon, Y.K., Kim, J.H., Glucocorticoids modulate NF-kappaB-dependent gene expression by up-regulating FKBP51 expression in Newcastle disease virus-infected chickens (2007) Mol Cell Endocrinol, 278, pp. 7-17
• Binder, E.B., Salyakina, D., Lichtner, P., Wochnik, G.M., Ising, M., Pütz, B., Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment (2004) Nat Genet, 36, pp. 1319-1325
• Zannas, A.S., Wiechmann, T., Gassen, N.C., Binder, E.B., Gene-stress-epigenetic regulation of FKBP5: clinical and translational implications (2016) Neuropsychopharmacology, 41, pp. 261-274
• Zimmermann, P., Brückl, T., Nocon, A., Pfister, H., Binder, E.B., Uhr, M., Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study (2011) Am J Psychiatry, 168, pp. 1107-1116
• De Bosscher, K., Haegeman, G., Minireview: latest perspectives on antiinflammatory actions of glucocorticoids (2009) Mol Endocrinol, 23, pp. 281-291
• Desmet, S.J., De Bosscher, K., Glucocorticoid receptors: finding the middle ground (2017) J Clin Invest, 127, pp. 1136-1145
• Surjit, M., Ganti, K.P., Mukherji, A., Ye, T., Hua, G., Metzger, D., Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor (2011) Cell, 145, pp. 224-241
• Hudson, W.H., Youn, C., Ortlund, E.A., The structural basis of direct glucocorticoid-mediated transrepression (2013) Nat Struct Mol Biol, 20, pp. 53-58
• Löwenberg, M., Stahn, C., Hommes, D.W., Buttgereit, F., Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands (2008) Steroids, 73, pp. 1025-1029
• Boldizsar, F., Talaber, G., Szabo, M., Bartis, D., Palinkas, L., Nemeth, P., Emerging pathways of non-genomic glucocorticoid (GC) signalling in T cells (2010) Immunobiology, 215, pp. 521-526
• Croxtall, J.D., Choudhury, Q., Flower, R.J., Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism (2000) Br J Pharmacol, 130, pp. 289-298
• Ayroldi, E., Cannarile, L., Migliorati, G., Nocentini, G., Delfino, D.V., Riccardi, C., Mechanisms of the anti-inflammatory effects of glucocorticoids: genomic and nongenomic interference with MAPK signaling pathways (2012) FASEB J, 26, pp. 4805-4820
• Scheinman, R.I., Gualberto, A., Jewell, C.M., Cidlowski, J.A., Baldwin, A.S., Jr., Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors (1995) Mol Cell Biol, 15, pp. 943-953
• De Bosscher, K., Vanden Berghe, W., Haegeman, G., The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression (2003) Endocr Rev, 24, pp. 488-522
• De Bosscher, K., Vanden Berghe, W., Haegeman, G., Cross-talk between nuclear receptors and nuclear factor kappaB (2006) Oncogene, 25, pp. 6868-6886
• Pascual, G., Glass, C.K., Nuclear receptors versus inflammation: mechanisms of transrepression (2006) Trends Endocrinol Metab, 17, pp. 321-327
• Jonat, C., Rahmsdorf, H.J., Park, K.K., Cato, A.C., Gebel, S., Ponta, H., Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone (1990) Cell, 62, pp. 1189-1204
• Helmberg, A., Auphan, N., Caelles, C., Karin, M., Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor (1995) EMBO J, 14, pp. 452-460
• Auphan, N., DiDonato, J.A., Rosette, C., Helmberg, A., Karin, M., Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis (1995) Science, 270, pp. 286-290
• Vacca, A., Felli, M.P., Farina, A.R., Martinotti, S., Maroder, M., Screpanti, I., Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements (1992) J Exp Med, 175, pp. 637-646
• De Bosscher, K., Schmitz, M.L., Vanden Berghe, W., Plaisance, S., Fiers, W., Haegeman, G., Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation (1997) Proc Natl Acad Sci U S A, 94, pp. 13504-13509
• Liberman, A.C., Refojo, D., Druker, J., Toscano, M., Rein, T., Holsboer, F., The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein-protein interaction (2007) FASEB J, 21, pp. 1177-1188
• John, S., Sabo, P.J., Johnson, T.A., Sung, M.H., Biddie, S.C., Lightman, S.L., Interaction of the glucocorticoid receptor with the chromatin landscape (2008) Mol Cell, 29, pp. 611-624
• John, S., Sabo, P.J., Thurman, R.E., Sung, M.H., Biddie, S.C., Johnson, T.A., Chromatin accessibility pre-determines glucocorticoid receptor binding patterns (2011) Nat Genet, 43, pp. 264-268
• De Bosscher, K., Beck, I.M., Haegeman, G., Classic glucocorticoids versus non-steroidal glucocorticoid receptor modulators: survival of the fittest regulator of the immune system? (2010) Brain Behav Immun, 24, pp. 1035-1042
• De Bosscher, K., Haegeman, G., Elewaut, D., Targeting inflammation using selective glucocorticoid receptor modulators (2010) Curr Opin Pharmacol, 10, pp. 497-504
• Liberman, A.C., Castro, C.N., Antunica Noguerol, M.A., Barcala Tabarrozzi, A.E., Druker, J., Perone, M.J., Immunomodulation by glucocorticoids: from basic research to clinical implications (2010) Curr Immunol Rev, 6, pp. 371-380
• Barnes, P.J., Glucocorticosteroids: current and future directions (2011) Br J Pharmacol, 163, pp. 29-43
• Vandevyver, S., Dejager, L., Van Bogaert, T., Kleyman, A., Liu, Y., Tuckermann, J., Glucocorticoid receptor dimerization induces MKP1 to protect against TNF-induced inflammation (2012) J Clin Invest, 122, pp. 2130-2140
• Ronchetti, S., Migliorati, G., Riccardi, C., GILZ as a mediator of the anti-inflammatory effects of glucocorticoids (2015) Front Endocrinol, 6, p. 170
• De Bosscher, K., Van Craenenbroeck, K., Meijer, O.C., Haegeman, G., Selective transrepression versus transactivation mechanisms by glucocorticoid receptor modulators in stress and immune systems (2008) Eur J Pharmacol, 583, pp. 290-302
• Belvisi, M.G., Wicks, S.L., Battram, C.H., Bottoms, S.E., Redford, J.E., Woodman, P., Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity (2001) J Immunol, 166, pp. 1975-1982
• De Bosscher, K., Beck, I.M., Dejager, L., Bougarne, N., Gaigneaux, A., Chateauvieux, S., Selective modulation of the glucocorticoid receptor can distinguish between transrepression of NF-kappaB and AP-1 (2014) Cell Mol Life Sci, 71, pp. 143-163
• De Bosscher, K., Vanden Berghe, W., Beck, I.M., Van Molle, W., Hennuyer, N., Hapgood, J., A fully dissociated compound of plant origin for inflammatory gene repression (2005) Proc Natl Acad Sci U S A, 102, pp. 15827-15832
• Vayssière, B.M., Dupont, S., Choquart, A., Petit, F., Garcia, T., Marchandeau, C., Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo (1997) Mol Endocrinol, 11, pp. 1245-1255
• Sugimoto, M.A., Vago, J.P., Teixeira, M.M., Sousa, L.P., Annexin A1 and the resolution of inflammation: modulation of neutrophil recruitment, apoptosis, and clearance (2016) J Immunol Res, 2016
• Errasfa, M., Russo-Marie, F., A purified lipocortin shares the anti-inflammatory effect of glucocorticosteroids in vivo in mice (1989) Br J Pharmacol, 97, pp. 1051-1058
• Buckingham, J.C., John, C.D., Solito, E., Tierney, T., Flower, R.J., Christian, H., Annexin 1, glucocorticoids, and the neuroendocrine-immune interface (2006) Ann N Y Acad Sci, 1088, pp. 396-409
• Barczyk, K., Ehrchen, J., Tenbrock, K., Ahlmann, M., Kneidl, J., Viemann, D., Glucocorticoids promote survival of anti-inflammatory macrophages via stimulation of adenosine receptor A3 (2010) Blood, 116, pp. 446-455
• Fadok, V.A., Bratton, D.L., Konowal, A., Freed, P.W., Westcott, J.Y., Henson, P.M., Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF (1998) J Clin Invest, 101, pp. 890-898
• Liu, Y., Cousin, J.M., Hughes, J., Van Damme, J., Seckl, J.R., Haslett, C., Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes (1999) J Immunol, 162, pp. 3639-3646
• McColl, A., Bournazos, S., Franz, S., Perretti, M., Morgan, B.P., Haslett, C., Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages (2009) J Immunol, 183, pp. 2167-2175
• Franchimont, D., Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies (2004) Ann N Y Acad Sci, 1024, pp. 124-137
• Sauer, J., Castren, M., Hopfner, U., Holsboer, F., Stalla, G.K., Arzt, E., Inhibition of lipopolysaccharide-induced monocyte interleukin-1 receptor antagonist synthesis by cortisol: involvement of the mineralocorticoid receptor (1996) J Clin Endocrinol Metab, 81, pp. 73-79
• Ehrchen, J., Steinmüller, L., Barczyk, K., Tenbrock, K., Nacken, W., Eisenacher, M., Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes (2007) Blood, 109, pp. 1265-1274
• Vallelian, F., Schaer, C.A., Kaempfer, T., Gehrig, P., Duerst, E., Schoedon, G., Glucocorticoid treatment skews human monocyte differentiation into a hemoglobin-clearance phenotype with enhanced heme-iron recycling and antioxidant capacity (2010) Blood, 116, pp. 5347-5356
• Ayroldi, E., Riccardi, C., Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action (2009) FASEB J, 23, pp. 3649-3658
• Cohen, N., Mouly, E., Hamdi, H., Maillot, M.C., Pallardy, M., Godot, V., GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response (2006) Blood, 107, pp. 2037-2044
• Elftman, M.D., Norbury, C.C., Bonneau, R.H., Truckenmiller, M.E., Corticosterone impairs dendritic cell maturation and function (2007) Immunology, 122, pp. 279-290
• Hamdi, H., Godot, V., Maillot, M.C., Prejean, M.V., Cohen, N., Krzysiek, R., Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipper (2007) Blood, 110, pp. 211-219
• Hontelez, S., Karthaus, N., Looman, M.W., Ansems, M., Adema, G.J., DC-SCRIPT regulates glucocorticoid receptor function and expression of its target GILZ in dendritic cells (2013) J Immunol, 190, pp. 3172-3179
• Luther, C., Adamopoulou, E., Stoeckle, C., Brucklacher-Waldert, V., Rosenkranz, D., Stoltze, L., Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients (2009) J Immunol, 183, pp. 841-848
• Rutella, S., Lemoli, R.M., Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications (2004) Immunol Lett, 94, pp. 11-26
• Cao, Y., Bender, I.K., Konstantinidis, A.K., Shin, S.C., Jewell, C.M., Cidlowski, J.A., Glucocorticoid receptor translational isoforms underlie maturational stage-specific glucocorticoid sensitivities of dendritic cells in mice and humans (2013) Blood, 121, pp. 1553-1562
• Cronstein, B.N., Kimmel, S.C., Levin, R.I., Martiniuk, F., Weissmann, G., A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1 (1992) Proc Natl Acad Sci U S A, 89, pp. 9991-9995
• Pitzalis, C., Pipitone, N., Bajocchi, G., Hall, M., Goulding, N., Lee, A., Corticosteroids inhibit lymphocyte binding to endothelium and intercellular adhesion: an additional mechanism for their anti-inflammatory and immunosuppressive effect (1997) J Immunol, 158, pp. 5007-5016
• Pitzalis, C., Pipitone, N., Perretti, M., Regulation of leukocyte-endothelial interactions by glucocorticoids (2002) Ann N Y Acad Sci, 966, pp. 108-118
• Weber, P.S., Toelboell, T., Chang, L.C., Tirrell, J.D., Saama, P.M., Smith, G.W., Mechanisms of glucocorticoid-induced down-regulation of neutrophil L-selectin in cattle: evidence for effects at the gene-expression level and primarily on blood neutrophils (2004) J Leukoc Biol, 75, pp. 815-827
• Besedovsky, L., Born, J., Lange, T., Endogenous glucocorticoid receptor signaling drives rhythmic changes in human T-cell subset numbers and the expression of the chemokine receptor CXCR4 (2014) FASEB J, 28, pp. 67-75
• Fischer, H.J., Schweingruber, N., Lühder, F., Reichardt, H.M., The potential role of T cell migration and chemotaxis as targets of glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis (2013) Mol Cell Endocrinol, 380, pp. 99-107
• Reichardt, H.M., Kaestner, K.H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., DNA binding of the glucocorticoid receptor is not essential for survival (1998) Cell, 93, pp. 531-541
• Bouillet, P., Metcalf, D., Huang, D.C., Tarlinton, D.M., Kay, T.W., Köntgen, F., Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity (1999) Science, 286, pp. 1735-1738
• Knudson, C.M., Tung, K.S., Tourtellotte, W.G., Brown, G.A., Korsmeyer, S.J., Bax-deficient mice with lymphoid hyperplasia and male germ cell death (1995) Science, 270, pp. 96-99
• Villunger, A., Michalak, E.M., Coultas, L., Müllauer, F., Böck, G., Ausserlechner, M.J., p53-and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa (2003) Science, 302, pp. 1036-1038
• Yin, X.M., Wang, K., Gross, A., Zhao, Y., Zinkel, S., Klocke, B., Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis (1999) Nature, 400, pp. 886-891
• Purton, J.F., Monk, J.A., Liddicoat, D.R., Kyparissoudis, K., Sakkal, S., Richardson, S.J., Expression of the glucocorticoid receptor from the 1A promoter correlates with T lymphocyte sensitivity to glucocorticoid-induced cell death (2004) J Immunol, 173, pp. 3816-3824
• Mosmann, T.R., Coffman, R.L., TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties (1989) Annu Rev Immunol, 7, pp. 145-173
• Farrar, J.D., Ouyang, W., Löhning, M., Assenmacher, M., Radbruch, A., Kanagawa, O., An instructive component in T helper cell type 2 (Th2) development mediated by GATA-3 (2001) J Exp Med, 193, pp. 643-650
• Ivanov, I.I., McKenzie, B.S., Zhou, L., Tadokoro, C.E., Lepelley, A., Lafaille, J.J., The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells (2006) Cell, 126, pp. 1121-1133
• Yang, X.O., Pappu, B.P., Nurieva, R., Akimzhanov, A., Kang, H.S., Chung, Y., T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma (2008) Immunity, 28, pp. 29-39
• Campbell, D.J., Ziegler, S.F., FOXP3 modifies the phenotypic and functional properties of regulatory T cells (2007) Nat Rev Immunol, 7, pp. 305-310
• Ramírez, F., Fowell, D.J., Puklavec, M., Simmonds, S., Mason, D., Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro (1996) J Immunol, 156, pp. 2406-2412
• Franchimont, D., Galon, J., Gadina, M., Visconti, R., Zhou, Y., Aringer, M., Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes (2000) J Immunol, 164, pp. 1768-1774
• Barnes, P.J., Th2 cytokines and asthma: an introduction (2001) Respir Res, 2, pp. 64-65
• Liberman, A.C., Druker, J., Refojo, D., Holsboer, F., Arzt, E., Glucocorticoids inhibit GATA-3 phosphorylation and activity in T cells (2009) FASEB J, 23, pp. 1558-1571
• Maneechotesuwan, K., Yao, X., Ito, K., Jazrawi, E., Usmani, O.S., Adcock, I.M., Suppression of GATA-3 nuclear import and phosphorylation: a novel mechanism of corticosteroid action in allergic disease (2009) PLoS Med, 6
• Biola, A., Andréau, K., David, M., Sturm, M., Haake, M., Bertoglio, J., The glucocorticoid receptor and STAT6 physically and functionally interact in T-lymphocytes (2000) FEBS Lett, 487, pp. 229-233
• Banuelos, J., Cao, Y., Shin, S.C., Lu, N.Z., Immunopathology alters Th17 cell glucocorticoid sensitivity (2017) Allergy, 72, pp. 331-341
• Ziolkowska, M., Koc, A., Luszczykiewicz, G., Ksiezopolska-Pietrzak, K., Klimczak, E., Chwalinska-Sadowska, H., High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism (2000) J Immunol, 164, pp. 2832-2838
• Momcilovic, M., Miljkovic, Z., Popadic, D., Markovic, M., Savic, E., Ramic, Z., Methylprednisolone inhibits interleukin-17 and interferon-gamma expression by both naive and primed T cells (2008) BMC Immunol, 9, p. 47
• McKinley, L., Alcorn, J.F., Peterson, A., Dupont, R.B., Kapadia, S., Logar, A., TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice (2008) J Immunol, 181, pp. 4089-4097
• Ramesh, R., Kozhaya, L., McKevitt, K., Djuretic, I.M., Carlson, T.J., Quintero, M.A., Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids (2014) J Exp Med, 211, pp. 89-104
• Schewitz-Bowers, L.P., Lait, P.J., Copland, D.A., Chen, P., Wu, W., Dhanda, A.D., Glucocorticoid-resistant Th17 cells are selectively attenuated by cyclosporine A (2015) Proc Natl Acad Sci U S A, 112, pp. 4080-4085
• Banuelos, J., Shin, S., Cao, Y., Bochner, B.S., Morales-Nebreda, L., Budinger, G.R., BCL-2 protects human and mouse Th17 cells from glucocorticoid-induced apoptosis (2016) Allergy, 71, pp. 640-650
• Zhao, J., Lloyd, C.M., Noble, A., Th17 responses in chronic allergic airway inflammation abrogate regulatory T-cell-mediated tolerance and contribute to airway remodeling (2013) Mucosal Immunol, 6, pp. 335-346
• Chen, X., Murakami, T., Oppenheim, J.J., Howard, O.M.Z., Differential response of murine CD4+CD25+ and CD4+CD25-T cells to dexamethasone-induced cell death (2004) Eur J Immunol, 34, pp. 859-869
• Chen, X., Oppenheim, J.J., Winkler-Pickett, R.T., Ortaldo, J.R., Howard, O.M., Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE (2006) Eur J Immunol, 36, pp. 2139-2149
• Braitch, M., Harikrishnan, S., Robins, R.A., Nichols, C., Fahey, A.J., Showe, L., Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis (2009) Acta Neurol Scand, 119, pp. 239-245
• Engler, J.B., Kursawe, N., Solano, M.E., Patas, K., Wehrmann, S., Heckmann, N., Glucocorticoid receptor in T cells mediates protection from autoimmunity in pregnancy (2017) Proc Natl Acad Sci U S A, 114, pp. E181-E190
• Wüst, S., van den Brandt, J., Tischner, D., Kleiman, A., Tuckermann, J.P., Gold, R., Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis (2008) J Immunol, 180, pp. 8434-8443
• Olsen, P.C., Kitoko, J.Z., Ferreira, T.P., de-Azevedo, C.T., Arantes, A.C., Martins, M.A., Glucocorticoids decrease Treg cell numbers in lungs of allergic mice (2015) Eur J Pharmacol, 747, pp. 52-58
• Sorrells, S.F., Caso, J.R., Munhoz, C.D., Sapolsky, R.M., The stressed CNS: when glucocorticoids aggravate inflammation (2009) Neuron, 64, pp. 33-39
• Butler, L.D., Layman, N.K., Riedl, P.E., Cain, R.L., Shellhaas, J., Evans, G.F., Neuroendocrine regulation of in vivo cytokine production and effects: I In vivo regulatory networks involving the neuroendocrine system, interleukin-1 and tumor necrosis factor-alpha (1989) J Neuroimmunol, 24, pp. 143-153
• Goujon, E., Parnet, P., Cremona, S., Dantzer, R., Endogenous glucocorticoids down regulate central effects of interleukin-1 beta on body temperature and behaviour in mice (1995) Brain Res, 702, pp. 173-180
• Goujon, E., Parnet, P., Layé, S., Combe, C., Dantzer, R., Adrenalectomy enhances pro-inflammatory cytokines gene expression, in the spleen, pituitary and brain of mice in response to lipopolysaccharide (1996) Brain Res Mol Brain Res, 36, pp. 53-62
• Masferrer, J.L., Seibert, K., Zweifel, B., Needleman, P., Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme (1992) Proc Natl Acad Sci U S A, 89, pp. 3917-3921
• Drew, P.D., Chavis, J.A., Inhibition of microglial cell activation by cortisol (2000) Brain Res Bull, 52, pp. 391-396
• Tanaka, J., Fujita, H., Matsuda, S., Toku, K., Sakanaka, M., Maeda, N., Glucocorticoid-and mineralocorticoid receptors in microglial cells: the two receptors mediate differential effects of corticosteroids (1997) Glia, 20, pp. 23-37
• Glezer, I., Munhoz, C.D., Kawamoto, E.M., Marcourakis, T., Avellar, M.C., Scavone, C., MK-801 and 7-Ni attenuate the activation of brain NF-kappa B induced by LPS (2003) Neuropharmacology, 45, pp. 1120-1129
• Blais, V., Turrin, N.P., Rivest, S., Cyclooxygenase 2 (COX-2) inhibition increases the inflammatory response in the brain during systemic immune stimuli (2005) J Neurochem, 95, pp. 1563-1574
• Blais, V., Zhang, J., Rivest, S., In altering the release of glucocorticoids, ketorolac exacerbates the effects of systemic immune stimuli on expression of proinflammatory genes in the brain (2002) Endocrinology, 143, pp. 4820-4827
• Nadeau, S., Rivest, S., Endotoxemia prevents the cerebral inflammatory wave induced by intraparenchymal lipopolysaccharide injection: role of glucocorticoids and CD14 (2002) J Immunol, 169, pp. 3370-3381
• Nadeau, S., Rivest, S., Glucocorticoids play a fundamental role in protecting the brain during innate immune response (2003) J Neurosci, 23, pp. 5536-5544
• Soulet, D., Rivest, S., Bone-marrow-derived microglia: myth or reality? (2008) Curr Opin Pharmacol, 8, pp. 508-518
• Carrillo-de Sauvage, Má., Maatouk, L., Arnoux, I., Pasco, M., Sanz Diez, A., Delahaye, M., Potent and multiple regulatory actions of microglial glucocorticoid receptors during CNS inflammation (2013) Cell Death Differ, 20, pp. 1546-1557
• Frank, M.G., Miguel, Z.D., Watkins, L.R., Maier, S.F., Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide (2010) Brain Behav Immun, 24, pp. 19-30
• Johnson, J.D., O'Connor, K.A., Deak, T., Stark, M., Watkins, L.R., Maier, S.F., Prior stressor exposure sensitizes LPS-induced cytokine production (2002) Brain Behav Immun, 16, pp. 461-476
• Johnson, J.D., O'Connor, K.A., Hansen, M.K., Watkins, L.R., Maier, S.F., Effects of prior stress on LPS-induced cytokine and sickness responses (2003) Am J Physiol Regul Integr Comp Physiol, 284, pp. R422-R432
• Hermoso, M.A., Matsuguchi, T., Smoak, K., Cidlowski, J.A., Glucocorticoids and tumor necrosis factor alpha cooperatively regulate toll-like receptor 2 gene expression (2004) Mol Cell Biol, 24, pp. 4743-4756
• Munhoz, C.D., Lepsch, L.B., Kawamoto, E.M., Malta, M.B., Lima Lde, S., Avellar, M.C., Chronic unpredictable stress exacerbates lipopolysaccharide-induced activation of nuclear factor-kappaB in the frontal cortex and hippocampus via glucocorticoid secretion (2006) J Neurosci, 26, pp. 3813-3820
• de Pablos, R.M., Villarán, R.F., Argüelles, S., Herrera, A.J., Venero, J.L., Ayala, A., Stress increases vulnerability to inflammation in the rat prefrontal cortex (2006) J Neurosci, 26, pp. 5709-5719
• Espinosa-Oliva, A.M., de Pablos, R.M., Villarán, R.F., Argüelles, S., Venero, J.L., Machado, A., Stress is critical for LPS-induced activation of microglia and damage in the rat hippocampus (2011) Neurobiol Aging, 32, pp. 85-102
• Frank, M.G., Thompson, B.M., Watkins, L.R., Maier, S.F., Glucocorticoids mediate stress-induced priming of microglial pro-inflammatory responses (2012) Brain Behav Immun, 26, pp. 337-345
• Frank, M.G., Watkins, L.R., Maier, S.F., Stress-and glucocorticoid-induced priming of neuroinflammatory responses: potential mechanisms of stress-induced vulnerability to drugs of abuse (2011) Brain Behav Immun, 25, pp. S21-S28
• Frank, M.G., Watkins, L.R., Maier, S.F., Stress-induced glucocorticoids as a neuroendocrine alarm signal of danger (2013) Brain Behav Immun, 33, pp. 1-6
• Blandino, P., Jr., Barnum, C.J., Solomon, L.G., Larish, Y., Lankow, B.S., Deak, T., Gene expression changes in the hypothalamus provide evidence for regionally-selective changes in IL-1 and microglial markers after acute stress (2009) Brain Behav Immun, 23, pp. 958-968
• Frank, M.G., Baratta, M.V., Sprunger, D.B., Watkins, L.R., Maier, S.F., Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses (2007) Brain Behav Immun, 21, pp. 47-59
• García-Bueno, B., Madrigal, J.L., Pérez-Nievas, B.G., Leza, J.C., Stress mediators regulate brain prostaglandin synthesis and peroxisome proliferator-activated receptor-gamma activation after stress in rats (2008) Endocrinology, 149, pp. 1969-1978
• Madrigal, J.L., Hurtado, O., Moro, M.A., Lizasoain, I., Lorenzo, P., Castrillo, A., The increase in TNF-alpha levels is implicated in NF-kappaB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress (2002) Neuropsychopharmacology, 26, pp. 155-163
• Madrigal, J.L., Moro, M.A., Lizasoain, I., Lorenzo, P., Fernández, A.P., Rodrigo, J., Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain (2003) Neuropsychopharmacology, 28, pp. 1579-1588
• O'Connor, K.A., Johnson, J.D., Hammack, S.E., Brooks, L.M., Spencer, R.L., Watkins, L.R., Inescapable shock induces resistance to the effects of dexamethasone (2003) Psychoneuroendocrinology, 28, pp. 481-500
• Ding, Y., Gao, Z.G., Jacobson, K.A., Suffredini, A.F., Dexamethasone enhances ATP-induced inflammatory responses in endothelial cells (2010) J Pharmacol Exp Ther, 335, pp. 693-702
• Lannan, E.A., Galliher-Beckley, A.J., Scoltock, A.B., Cidlowski, J.A., Proinflammatory actions of glucocorticoids: glucocorticoids and TNFalpha coregulate gene expression in vitro and in vivo (2012) Endocrinology, 153, pp. 3701-3712
• De Bosscher, K., Selective glucocorticoid receptor modulators (2010) J Steroid Biochem Mol Biol, 120, pp. 96-104

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------